Matthew Kappus
Appearances
- DateMay 8, 2023BACKGROUND: Hepatorenal syndrome (HRS) with rapidly deteriorating kidney function can be effectively reversed when treated with terlipressin, the US FDA-approved vasopressin analogue…
Presenter
Speakers
Baylor University Medical CenterUniversity of Arkansas for Medical SciencesUniversity of AlbertaColumbia University Medical Center - DateMay 20, 2024BACKGROUND: The Model for End-Stage Liver Disease-Sodium (MELDNa) is an established metric of 3-month waitlist mortality (WLM) in cirrhosis patients but underestimates mortality risk in certain subgroups…
Presenter
Speakers
University of Arkansas for Medical Sciences